Increased NO-synthase activity and beneficial effect of PDE-5 inhibition by sildenafil in pulmonary hypertension caused by pulmonary embolism

被引：0
|
作者：
Mizera, Roman [1 ,2 ]
Hodyc, Daniel [1 ]
Herget, Jan [1 ]
机构：
[1] 2nd Med Sch Prague, Prague 5, Czech Republic
[2] KNL, Traumatol Orthopad Ctr, Liberec 1, Czech Republic
来源：
FASEB JOURNAL | 2014年 / 28卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
LB646
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Effect of Phosphodiesterase-5 (PDE-5) Inhibitors on Clinical Outcomes in Patients With Pulmonary Hypertension: A Meta-Analysis of Randomized Control Trials
    Karedath, Jithin
    Dar, Hassaan
    Ganipineni, Vijay Durga Pradeep
    Gorle, Sri Anjali
    Gaddipati, Sarvani
    Bseiso, Anan
    Pizzorno, Guiomarly
    Shaik, Tanveer Ahamad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
  • [32] ARTERIAL METHEMOGLOBIN LEVEL PREDICTS THERAPEUTIC EFFECTIVENESS OF THE PDE-5 INHIBITORS IN PATIENTS WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION
    Ono, Tomohiko
    Tamura, Yuichi
    Kawakami, Takashi
    Kataoka, Masaharu
    Sano, Motoaki
    Satoh, Toru
    Fukuda, Keiichi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E1462 - E1462
  • [33] Initial Combination Therapy With Endothelin Receptor Antagonist And Pde-5 Inhibitor In Inoperable Chronic Thromboembolic Pulmonary Hypertension
    Sitbon, O.
    Bourlier, D.
    Jais, X.
    Cottin, V.
    Savale, L.
    Bergot, E.
    Dauphin, C.
    Bouvaist, H.
    Langlard, D. Horeau
    Tetu, L.
    Bauer, F.
    Dromer, C.
    Montani, D.
    Humbert, M.
    Simonneau, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [34] Beneficial effect of oral sildenafil on cardiac function and ventricular remodelling in patients with pulmonary arterial hypertension
    Prasad, SK
    Mikhail, G
    Rogers, P
    Smith, G
    Pennell, DJ
    Kilner, P
    Gatzoulis, M
    CIRCULATION, 2003, 108 (17) : 643 - 644
  • [35] SHORT TERM EFFECT OF SILDENAFIL ON PULMONARY ARTERIAL PRESSURE AND PLATELET ACTIVITY THALASSEMIA PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION
    Tanjararak, Navy
    Chuncharunee, Suporn
    Srihirun, Sirada
    Sibmooh, Nathawut
    Yamwong, Sukit
    Wattanachai, Somruthai
    Sritara, Piyamitr
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A1482 - A1482
  • [36] EFFECT OF PHOSPHODIESTERASE 5(PDE5) ANTAGONISTS ON PULMONARY AND CEREBRAL ARTERIES OF PIGLETS WITH HYPOXIA-INDUCED PULMONARY HYPERTENSION
    Fike, Candice Denise
    Kaplowitz, Mark R.
    Zhang, Yongmei
    Dantuma, Mark
    Madden, Jane A.
    JOURNAL OF PHYSIOLOGICAL SCIENCES, 2009, 59 : 263 - 263
  • [37] Elevation of pulmonary PDE5-specific activity in an experimental fetal ovine perinatal pulmonary hypertension model.
    Hanson, KA
    Abman, SH
    Clarke, WR
    PEDIATRIC RESEARCH, 1996, 39 (04) : 1990 - 1990
  • [38] SHORT TERM EFFECT OF SELEXIPAG IN COMPARISON TO PROSTACYCLIN ANALOGUES IN PULMONARY ARTERIAL HYPERTENSION PATIENTS STARTED ON DOUBLE-COMBINATION THERAPY WITH ERA AND PDE-5 INHIBITORS
    Dardi, Fabio
    Palazzini, Massimiliano
    Zuffa, Elisa
    De Lorenzis, Alessandro
    Guarino, Daniele
    Pasca, Filippo
    Magnani, Ilenia
    Rotunno, Mariangela
    Ballerini, Alberto
    Manes, Alessandra
    Galie, Nazzareno
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 2097 - 2097
  • [39] Mitochondrial oxidant stress increases PDE5 activity in persistent pulmonary hypertension of the newborn
    Farrow, Kathryn N.
    Wedgwood, Stephen
    Lee, Keng Jin
    Czech, Lyubov
    Gugino, Sylvia F.
    Lakshminrusimha, Satyan
    Schumacker, Paul T.
    Steinhorn, Robin H.
    RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2010, 174 (03) : 272 - 281
  • [40] Long-term therapy of interferon-alpha induced pulmonary arterial hypertension with different PDE-5 inhibitors: A case report
    Jochmann N.
    Kiecker F.
    Borges A.C.
    Hofmann M.A.
    Eddicks S.
    Sterry W.
    Baumann G.
    Trefzer U.
    Cardiovascular Ultrasound, 3 (1)
12345